Search

everythinglearnresearchcommunity

for

Search:↓

Small molecule DMF improves psoriasis and multiple sclerosis, adult skin cells can be made to grow new hair, certain skin cells initiate hair growth, IL-17C controls gut health and can cause skin inflammation, and skin cells produce IL-17 that can lead to psoriasis.

Some vitamin D analogs can thicken skin and reduce pore size like a common acne treatment, with one analog also affecting skin growth factors.

The patient's symptoms improved with treatment but recurred when the steroid dose was reduced, requiring ongoing therapy.

The MPA-ISO cocrystal improved solubility and dissolution rate, while the others did not.

Combining hydroxychloroquine and pimecrolimus can effectively treat hair loss from discoid lupus.

Tofacitinib improved hair loss and skin symptoms in a patient after secukinumab caused hair loss.

IL-17C is important in inflammatory skin diseases and could be a target for treatment.

A protein called IL-36γ causes skin side effects from certain cancer treatments when combined with a common skin bacteria.

PPAR agonists show promise for skin conditions but need more research before being a main treatment.

IL-24 contributes to skin aging by increasing collagen-degrading enzymes and decreasing collagen production when exposed to air pollution.

Prednisone reduces organ mast cell infiltration but does not alter the abnormal appearance of mast cells in systemic mastocytosis.

Dupilumab and oral JAK inhibitors are effective for treating alopecia areata with atopic diseases.

Panitumumab treatment can cause unusual hair growth in some colorectal cancer patients.

An 84-year-old man got a rare scalp condition from using imiquimod cream, which was cured with systemic steroids.

Certain peptides can prevent hair loss in young rats caused by a cancer drug.

A patient got a skin reaction on their hands and feet after using secukinumab for psoriasis.

Topical immunotherapy with DPCP led to some hair regrowth in most pediatric alopecia areata patients, especially those with milder cases and longer treatment.

The new anti-acne treatment HA-P5 effectively reduces acne by targeting two key receptors and avoids an enzyme that can hinder treatment.

Some moles can disappear naturally, maintenance therapy for Stage 1 mycosis fungoides may not be necessary, allergic skin reactions in children are rising, weekly methotrexate for psoriasis is more effective than daily, long-term finasteride use improves hair growth with few side effects, and petrolatum improves UV therapy for psoriasis.

Modified phenol peels effectively reduced stubborn skin pigmentation in patients with Lichen Planus Pigmentosus.

Mycophenolate mofetil is a good alternative for autoimmune hepatitis patients who can't tolerate azathioprine.

Special immune cells called Tregs can help prevent lung scarring by blocking a specific growth factor.

Oleoylethanolamide (OEA) safely boosts fat production in skin cells and may help treat dry skin and reduce inflammation.

All four treatments for early rheumatoid arthritis had similar and mostly mild side effects.

Dermal EZH2 controls skin cell growth and differentiation in mice.

Platelet-rich plasma therapy could be an effective treatment for melasma with minimal side effects.

Omalizumab can cause temporary hair loss but still works well for chronic urticaria.

Adalimumab helped control a child's severe eye disease when other treatments failed.